IDRI Offers Flu Vaccine Boosters

Xconomy Seattle — 

The Infectious Disease Research Institute, a Seattle-based nonprofit research center, said today it it is offering a critical ingredient to manufacturers that could increase the world supplies of flu vaccine. IDRI has developed adjuvants, or immune-boosting compounds, that make it possible to give smaller doses that can still protect people against infection. The announcement came shortly after the World Health Organization officially declared a global swine flu pandemic.